Journal of veterinary internal medicine · 2026
Efficacy of intra-urethral lidocaine jelly administration for prevention of post-cystoscopy dysuria in dogs.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Slead Tanner S, Kendall Allison R, Secoura Patty L, Wass Kara, Harris Tonya L, Moore George E, Vaden Shelly
Аннотация
BACKGROUND: Post-cystoscopy dysuria is thought to be common in dogs. Limited information is available in veterinary medicine regarding strategies to prevent or mitigate post-cystoscopy dysuria.
HYPOTHESIS/OBJECTIVES: Determine the efficacy of intraurethrally administered lidocaine jelly in combination with current standard-of-care pain control (eg, epidural anesthesia, nonsteroidal anti-inflammatory drugs) for prevention of post-cystoscopy dysuria.
ANIMALS: Fifty-one client-owned dogs presented for cystoscopy or other cystoscopically guided interventions.
METHODS: Randomized, placebo-controlled, double-blinded, and clinical study. All dogs undergoing cystoscopy for common indications were considered for enrollment during the study period with owner permission. Dysuria scores were compared between groups on days 0-7.
RESULTS: Twenty-six dogs were included in the lidocaine group and 25 in the placebo group. No significant difference was found in the frequency of postprocedure dysuria between groups. Twenty percent of all dogs exhibited dysuria on day 1 after cystoscopy, but decreased to 11% by day 5 (P < .001).
CONCLUSIONS AND CLINICAL IMPORTANCE: Intraurethral administration of lidocaine jelly might not be necessary to decrease the frequency and duration of postprocedural dysuria. Dysuria resolved in most patients undergoing cystoscopy by day 4. This information might be helpful for owner education and preparation of dogs for cystoscopic procedures.
HYPOTHESIS/OBJECTIVES: Determine the efficacy of intraurethrally administered lidocaine jelly in combination with current standard-of-care pain control (eg, epidural anesthesia, nonsteroidal anti-inflammatory drugs) for prevention of post-cystoscopy dysuria.
ANIMALS: Fifty-one client-owned dogs presented for cystoscopy or other cystoscopically guided interventions.
METHODS: Randomized, placebo-controlled, double-blinded, and clinical study. All dogs undergoing cystoscopy for common indications were considered for enrollment during the study period with owner permission. Dysuria scores were compared between groups on days 0-7.
RESULTS: Twenty-six dogs were included in the lidocaine group and 25 in the placebo group. No significant difference was found in the frequency of postprocedure dysuria between groups. Twenty percent of all dogs exhibited dysuria on day 1 after cystoscopy, but decreased to 11% by day 5 (P < .001).
CONCLUSIONS AND CLINICAL IMPORTANCE: Intraurethral administration of lidocaine jelly might not be necessary to decrease the frequency and duration of postprocedural dysuria. Dysuria resolved in most patients undergoing cystoscopy by day 4. This information might be helpful for owner education and preparation of dogs for cystoscopic procedures.